unic msc digital currency Top Knowledge

Citic Jiantou Pharmaceutical's 2025 strategy: looking for new additions and integration opportunities. Citic Jiantou said that looking forward to 2025, the reform policy in the medical field has been normalized, and the most noteworthy incremental policy in the medical insurance field is to establish a diversified payment system. The medical field is about to usher in the reform of "deep water areas" such as salary system and graded diagnosis and treatment, which is in line with expectations as a whole. At the same time, the innovation of China's pharmaceutical industry has gradually stepped onto the international stage, some sub-sectors will be marginally improved, and industry integration will begin. We are optimistic about the investment opportunities in the pharmaceutical industry in 2025. It is suggested to focus on the new increase (innovation, going out to sea, marginal change) and industry integration opportunities.The restricted shares with a market value of 644 million yuan were lifted today. Xishan Technology, Betray and Wanda Bearing were among the top companies in terms of market value. On Friday (December 13th), the restricted shares of eight companies were lifted, with a total lifting amount of 20,925,400 shares. According to the latest closing price, the total lifting market value was 644 million yuan. Judging from the amount of lifting the ban, Betray, Xishan Technology and Nanwang Technology were among the top, with 9,834,300 shares, 3,706,800 shares and 3,247,500 shares respectively. Judging from the market value of lifting the ban, the number of shares lifted by 0 companies exceeded 100 million yuan. Xishan Technology, Betray and Wanda Bearing are among the top companies in terms of market value, with market values of 246 million yuan, 229 million yuan and 76.73 million yuan respectively. From the perspective of the proportion of shares released from the ban to the total share capital, Xishan Technology, Wanda Bearing and Nanwang Technology are among the top, with 7.47%, 3.08% and 1.66% respectively.People's Daily: Ensure that artificial intelligence is always a "friend". At present, the ability of artificial intelligence is comparable to that of human brain in many aspects, but it cannot accurately distinguish right from wrong in terms of value. This means that it is necessary to strengthen the supervision and regulation of artificial intelligence from many aspects. In recent years, many countries, including China, have introduced artificial intelligence development plans, management methods and supervision principles, precisely to ensure that technology truly serves people and benefits society. No matter how far artificial intelligence develops, it all comes from human design and is an extension of human wisdom. Artificial intelligence is doing more and more work and becoming more and more intelligent. We must take precautions to ensure that it is always a "friend".

CITIC Jiantou: The domestic cross-border e-commerce industrial chain has been gradually improved. CITIC Jiantou said that from 2010 to 2014, China's cross-border e-commerce entered a stage of rapid development. With the rise of mobile Internet infrastructure and the penetration rate of overseas cross-border e-commerce giants in the Mainland, the supporting facilities of the industrial chain have been gradually improved, subdivided and specialized, relevant policies have continued to exert their strength, and the customs supervision model has gradually become clear; Cross-border e-commerce industry chain is long, and there are relatively many hidden risk points because it involves cross-border. The cost structure of each link is mainly different due to the differences in participation roles, platform models, product types, warehousing and logistics structures, etc. Overall, the current cost structure is relatively stable, but there is also a large room for optimization. The degree of specialization and refinement of service providers will be improved, and the overall control, collaboration and empowerment of the industry chain and the refined arrangement led by big data and industry cognition will become one of the core competitiveness.Li Tie's family members were not present at the trial today, and the verdict in the first instance of Li Tie's case will start at 8:30 on time today. It is understood that after the trial today, it will directly enter the sentencing procedure, and the presiding judge will read the verdict and then ask the parties whether to appeal. Besides, apart from the defense lawyer, Li Tie's family did not come to the scene. (CCTV)The UN Secretary-General is deeply concerned about the extensive violation of Syrian sovereignty. On the 12th, UN Secretary-General Guterres issued a statement through spokesman Dujaric, expressing deep concern about the recent extensive violation of Syrian sovereignty and territorial integrity, especially the hundreds of Israeli air strikes against Syria. The statement said that the Disengagement of Forces Agreement signed in 1974 is still valid. Guterres condemned all violations of the agreement and called on all parties to fulfill their relevant obligations, including ending all unauthorized presence in the isolation zone and avoiding any actions that undermine the ceasefire and stability in the Golan Heights. (Xinhua News Agency)

Apple is reported to cooperate with Broadcom to develop AI chips, and TSMC's advanced process will welcome big orders again. On December 13, it was reported that Apple intends to invest in self-developed AI chips, jointly develop them with Broadcom, and produce them in TSMC's 3 nm process, and mass-produce them in 2026. The legal person is optimistic that after the development of Apple's self-developed AI chip is completed, the investment is expected, and TSMC's advanced process will usher in another big order. It is understood that Apple's current A-series processors for iPhone and M-series processors for Mac all adopt self-developed strategies, and are exclusively manufactured by TSMC. The legal person believes that once Apple's self-developed chips are extended to AI chips, the cooperation with TSMC will be closer. (Taiwan Province Economic Daily)Employees hide $154 million in accounts. Macy's said that internal control was ineffective. On Thursday, Macy's said that a reassessment of its financial situation showed that as of February this year, the internal control (including proper record maintenance) of the chain department store was not effective. The retailer launched an evaluation at the end of November after discovering that an employee had concealed as much as $154 million in expenses for many years. Therefore, the company postponed the release of the third quarter earnings report until December 11th. Macy's said that under the supervision of the board of directors, Tony Spring, its CEO, and Adrian Mitchell, its chief financial officer, re-evaluated the effectiveness of internal control, and pointed out that its financial report was not effective as of February 3 due to major defects. The department store chain said that it is implementing changes to improve internal control and make up for major defects.Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.